Nonsteroidal anti-inflammatory drug use does not affect short-term endoscopic and histologic outcomes after Helicobacter pylori eradication in patients with rheumatoid arthritis

References

• Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994;89: S116–28.
   PubMedGoogle Scholar
• Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175–86.
   PubMed Web of Science ®Google Scholar
• Ofman JJ, MacLean CH, Straus WL, Morton SC, Berger ML, Roth EA, et al. A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. J Ftheuma-tol 2002;29:804–12.
   PubMed Web of Science ®Google Scholar
• Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999;340: 1888–99.
   PubMed Web of Science ®Google Scholar
• Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991; 115:787–96.
   Google Scholar
• Huang JO, Sridhar S, Hunt RH. Role of Helicobacter pylori infec-tion and non-steroidal anti-inflammatory drugs in peptic-ulcer dis-ease: a meta-analysis. Lancet 2002;359:14–22.
   Google Scholar
• Bianchi Porro G, Parente F, Imbesi V, Montrone F, Caruso I. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omepra-zole dual therapy. Gut 1996;39:22–6.
   Google Scholar
• Chan FK, Sung JJ, Chung SC, To KF, Yung MY, Leung VK, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. 22. Lancet 1997;350:975–9.
   PubMed Web of Science ®Google Scholar
• Hawkey CJ, Tulassay Z, Szczepanski L, van Rensburg CJ, Filipowicz-Sosnowska A, Lanas A, et al. Randomised controlled 23. trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention. Lancet 1998;352: 1016–21.
   Google Scholar
• Chan FK, Sung JJ, Suen R, Lee YT, Wu JC, Leung WK, et al. Does 24. eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study. Aliment Pharmacol Ther 1998;12: 1201-5.25.
   Google Scholar
• Chan FK, Chung SC, Suen BY, Lee YT, Leung WK, Leung VK, et al. Preventing recurrent upper gastrointestinal bleeding in pa-tients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001;344:967-73.26.
   Google Scholar
• Chan FK, To KF, Wu JC, Yung MY, Leung WK, Kwok T, et al. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti- inflammatory drugs: a randomised trial. Lancet 2002;359:9-13.27.
   Google Scholar
• Bannwarth B, Dorval E, Caekaert A, Barthelemy P. Influence of Helicobacter pylori eradication therapy on the occurrence of gastrointestinal events in patients treated with conventional 28. nonsteroidal antiinflammatory drugs combined with omeprazole. J Ftheumatol 2002;29:1975–80.
   Google Scholar
• Lai KC, Lau CS, Ip WY, Wong BC, Hui WM, Hu WH, et al. Effect of treatment of Helicobacter pylori on the prevention of 29. gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebo-controlled trial. Aliment Pharmacol Ther 30. 2003;17: 799–805.
   Google Scholar
• Yeomans ND, Tulassay Z, Juhasz L, Racz I, Howard JM, van Rensburg CJ, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. 31. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 1998;338: 719–26.32.
   Google Scholar
• Hawkey CJ, Karrasch JA, Szczepanski L, Walker DG, Barkun A, Swannell AJ, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. 33. Omeprazole versus Misoprostol for NSAID -induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998; 338:727–34.
   Google Scholar
• Haruma K, Kamada T, Kawaguchi H, Okamoto S, Yoshihara M, 34. Sumii K, et al. Effect of age and Helicobacter pylori infection on gastric acid secretion. J Gastroenterol Hepatol 2000;15:277–83.
   Google Scholar
• Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Sumii K, 35. Kajiyama G. Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol 1996;91:959–62.
   PubMed Web of Science ®Google Scholar
• Asaka M, Kato M, Kudo M, Katagiri M, Nishikawa K, Koshiyama H, et al. Atrophic changes of gastric mucosa are caused by Helico- 36. bacter pylori infection rather than aging: studies in asymptomatic Japanese adults. Helicobacter 1996;1: 52–6.
   Google Scholar
• Uemura N, Okamoto S. Effect of Helicobacter pylori eradication 37. on subsequent development of cancer after endoscopic resection of early gastric cancer in Japan. Gastroenterol Clin North Am 2000;29:819–27.
   Google Scholar
• Yasunaga Y, Shinomura Y, Kanayama S, Yabu M, Nakanishi T, 38. Miyazaki Y, et al. Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associ-ated enlarged fold gastritis. Gut 1994;35:1571–4.
   Google Scholar
• Asaka M. Helicobacter pylori and gastroduodenal diseases (in Japanese). In: Asaka M, editor. Gastric cancer. Tokyo: Sentan Igakusha; 1999. p. 116–26.
   Google Scholar
• Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992;102: 760–6.
   PubMed Web of Science ®Google Scholar
• Matsuda Y, Singh G, Yamanaka H, Tanaka E, Urano W, Taniguchi A, et al. Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheuma-toid arthritis. Arthritis Rheum 2003;49:784–8.
   PubMed Web of Science ®Google Scholar
• Tanaka E, Singh G, Saito A, Syouji A, Yamada T, Urano W, et al. Prevalence of Helicobacter pylori infection and risk of upper gas-trointestinal ulcer in patients with rheumatoid arthritis in Japan. Mod Ftheumatol 2005;15:340–5.
   PubMedGoogle Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Kawai T, Kawakami K, Kudo T, Ogiahara S, Handa Y, Moriyasu F. A new serum antibody test kit (E plate) for evaluation of Heli-cobacter pylori eradication. Intern Med 2002;41:780–3.
   PubMedGoogle Scholar
• Fujioka T, Tokieda M. Validity of serum anti-Helicobacter pylori antibody using enzyme immunoassay for the diagnosis in eradica-tion of Helicobacter pylori (in Japanese). Jpn J Med Pharm Sci 2000;43:573–9.
   Google Scholar
• Misiewicz JJ. The Sydney System: a new classification of gastritis. J Gastroenterol Hepatol 1991;6:207–8.
   PubMed Web of Science ®Google Scholar
• Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20: 1161–81.
   Google Scholar
• Chan FK, Sung JJ. How does Helicobacter pylori infection interact with non-steroidal anti-inflammatory drugs? Baillieres Best Pract Res Chin Gastroenterol 2000;14:161–72.
   PubMedGoogle Scholar
• Yeomans ND, Garas G, Hawkey CJ. The nonsteroidal anti-inflammatory drugs controversy. Gastroenterol Clin North Am 2000;29:791–805.
   PubMedGoogle Scholar
• Hudson N, Balsitis M, Filipowicz F, Hawkey CJ. Effect of Helico-bacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 1993;34:748–51.
   PubMed Web of Science ®Google Scholar
• el-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterolo-gy 1995;109:681–91.
   Google Scholar
• Shiokawa Y, Nobunaga M, Saito T, Asaki S, Ogawa N. Epidemiology study on upper gastrointestinal lesions induced by non-steroidal anti-inflammatory drugs (in Japanese). Ryumachi 1991;31:96–111.
   Google Scholar
• Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of He-licobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003;326:737.
   PubMed Web of Science ®Google Scholar
• Plein K, Madisch A, Stolte M, Hotz J. Short-term changes in Helicobacter pylori gastritis and bulbitis during and after 2 weeks of treatment with omeprazole and amoxicillin in duodenal ulcer patients. Z Gastroenterol 2001;39:503–10.
   PubMedGoogle Scholar
• Urakami Y, Sano T. Endoscopic duodenitis, gastric metaplasia and Helicobacter pylori. J Gastroenterol Hepatol 2001;16:513–8.
   PubMedGoogle Scholar